Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug. [electronic resource]
Producer: 20080724Description: 1000-5 p. digitalISSN:- 1462-0332
- Adalimumab
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- drug therapy
- Disability Evaluation
- Etanercept
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin G -- adverse effects
- Infliximab
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Registries
- Severity of Illness Index
- Treatment Failure
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.